Skip to main content

Table 2 Univariable and multivariable analysis of progression-free survival in HRD cohort (n = 118)

From: Homologous recombination deficiency status predicts response to platinum-based chemotherapy in Chinese patients with high-grade serous ovarian carcinoma

Factors

Univariable Analysis

Multivariable Analysis

 

HR

95%CI

P valuea

HR

95%CI

P value

HRD score

0.64

0.41–0.98

0.04

0.92

0.38–2.23

0.854

HRD status

0.44

0.29–0.68

 < 0.001

0.62

0.22–1.71

0.356

Residual tumor

0.45

0.29–0.70

 < 0.001

0.47

0.30–0.74

0.001

tBRCA

0.54

0.33–0.9

0.017

0.66

0.32–1.38

0.272

  1. Abbreviations: tBRCA   Tumor BRCA, HR   Hazard ratio
  2. a Adjusted with a Bonferroni correction